MEKONOS
San Francisco, US · Founded 2017 · Delaware corporation · 4 known investors
Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.
Biotech
Founders & leadership
MEKONOS was founded in 2017 by Anil Narasimha.
AN
Anil NarasimhaFounder
Board
KK
NT
Neil TiwariBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$29.5M disclosed across 2 rounds · 2020–2021
▶$25MraisedNov 2021 · 23 investors · BiotechnologyRule 506(b)
▶$25MraisedNov 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kurt KeilhackerDirector
- Neil TiwariDirector
- Anil NarasimhaExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.5MraisedDec 2020 · 16 investors · OtherRule 506(b)
▶$4.5MraisedDec 2020 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anil NarasimhaExecutive Officer, Director
- Kurt KeilhackerDirector
- Gregory SittersExecutive Officer
- Offering amount
- $5.9M
- Amount sold
- $4.5M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does MEKONOS do?
- Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.
- Who founded MEKONOS?
- MEKONOS was founded by Anil Narasimha in 2017.
- Who are MEKONOS's investors?
- MEKONOS's investors include Booster Innovation Fund, Good AI Capital, Matū, Elementum Ventures.
- How much funding has MEKONOS raised?
- MEKONOS has disclosed $29.5M raised across 2 rounds.
- Where is MEKONOS headquartered?
- MEKONOS is headquartered in San Francisco, US.